These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12010574)

  • 21. A new approach to the molecular characterization of the c-ANCA antigen in Wegener's granulomatosis.
    Bleil L; Winkler TH; Fehr HK; Bautz EK; Kalden JR
    Adv Exp Med Biol; 1993; 336():51-4. PubMed ID: 8296666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinase 3, Wegener's autoantigen: from gene to antigen.
    van der Geld YM; Limburg PC; Kallenberg CG
    J Leukoc Biol; 2001 Feb; 69(2):177-90. PubMed ID: 11272267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis.
    Rarok AA; Stegeman CA; Limburg PC; Kallenberg CG
    J Am Soc Nephrol; 2002 Sep; 13(9):2232-8. PubMed ID: 12191967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro interactions of c-ANCA (antibodies to proteinase 3) with human endothelial cells.
    Mayet WJ; Hermann EM; Csernok E; Gross WL; Meyer zum Büschenfelde KH
    Adv Exp Med Biol; 1993; 336():109-13. PubMed ID: 8296598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia?
    Blockmans D; Stevens E; Mariën G; Bobbaers H
    Ann Rheum Dis; 1998 Mar; 57(3):141-5. PubMed ID: 9640128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
    van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
    Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteinase 3 gene polymorphisms and Wegener's granulomatosis.
    Gencik M; Meller S; Borgmann S; Fricke H
    Kidney Int; 2000 Dec; 58(6):2473-7. PubMed ID: 11115080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane proteinase 3 and Wegener's granulomatosis.
    von Vietinghoff S; Schreiber A; Otto B; Choi M; Göbel U; Kettritz R
    Clin Nephrol; 2005 Dec; 64(6):453-9. PubMed ID: 16370159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene structure of ANCA target antigens: implications for the pathogenesis of vasculitis.
    Jenne DE
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):209-13. PubMed ID: 8946583
    [No Abstract]   [Full Text] [Related]  

  • 33. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
    Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
    Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.
    Gaskin G; Kendal H; Coulthart A; Turner N; Pusey CD
    J Immunol Methods; 1995 Mar; 180(1):25-33. PubMed ID: 7897245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.
    Clayton AR; Savage CO
    Arthritis Res; 2000; 2(4):260-2. PubMed ID: 11094438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current knowledge on cellular interactions in the WG-granuloma.
    Lamprecht P; Gross WL
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S49-51. PubMed ID: 17428367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of Wegener's granulomatosis.
    Gross WL; Trabandt A; Csernok E
    Ann Med Interne (Paris); 1998 Sep; 149(5):280-6. PubMed ID: 9791561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis.
    Csernok E; Holle JU; Gross WL
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S112-7. PubMed ID: 18799068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3.
    King WJ; Adu D; Daha MR; Brooks CJ; Radford DJ; Pall AA; Savage CO
    Clin Exp Immunol; 1995 Oct; 102(1):98-105. PubMed ID: 7554407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
    Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears A; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S45-52. PubMed ID: 19646346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.